King Pharmaceuticals®, Inc., Acura Pharmaceuticals, Inc. Pain Drug Gets Priority Review

March 3 (Reuters) - Acura Pharmaceuticals Inc and King Pharmaceuticals Inc said U.S. health regulators granted a priority review for their experimental pain drug Acurox.